The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Holveck David since year 2005.
The trader's CIK number is 1429993.
At the time of this reporting, Holveck David is the President & CEO of Endo Pharmaceuticals Holdings Inc .
(stock ticker symbol ENDP).
See this page for all insider trading activities at Endo Pharmaceuticals Holdings Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-12-31||ENDP||Endo Pharmaceuticals Holdings Inc||Option Ex||89,155||.00||0|
|2012-11-12||ENDP||Endo Pharmaceuticals Holdings Inc||Buy||7,425||26.84||199,287|
|2012-06-12||ENDP||Endo Pharmaceuticals Holdings Inc||Buy||8,550||29.23||249,916|
|2011-08-25||ENDP||Endo Pharmaceuticals Holdings Inc||Buy||8,200||30.30||248,468|
|2011-02-23||ENDP||Endo Pharmaceuticals Holdings Inc||Option Ex||103,826||.00||0|
|2009-03-10||ENDP||Endo Pharmaceuticals Holdings Inc||Buy||28,964||16.74||484,828|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Holveck David (President & CEO of Endo Pharmaceuticals Holdings Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.